Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: A collaborative analysis of prospective studies
High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub-Saharan Africa, compared to Europe and North America, is well documented. Longer-term comparisons between settings have been limited by poor ascertainment of mortality in high burden African settings. This study aimed to compare mortality up to four years on ART between South Africa, Europe, and North America.
Publication Date:
09/09/2014
11
9
1-14